Arcus Biosciences logo
Arcus Biosciences RCUS
$ 21.6 -0.23%

Annual report 2025
added 02-25-2026

report update icon

Arcus Biosciences DSO Ratio 2011-2026 | RCUS

Annual DSO Ratio Arcus Biosciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - 3.21 3.63 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.63 3.21 3.42

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Heron Therapeutics Heron Therapeutics
HRTX
198 $ 0.79 1.9 % $ 132 M usaUSA
Altimmune Altimmune
ALT
7.85 K $ 3.44 2.99 % $ 303 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 218.03 -1.74 % $ 5 B danmarkDanmark
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Incyte Corporation Incyte Corporation
INCY
66.6 $ 90.43 -0.21 % $ 17.7 B usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
1.91 K $ 1.54 -2.41 % $ 34.1 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
475 $ 16.82 -1.06 % $ 835 M britainBritain
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
103 $ 8.27 0.24 % $ 260 M israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
60.8 $ 2.13 1.67 % $ 199 M israelIsrael
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
72.5 $ 7.11 -6.82 % $ 866 K usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
1.89 $ 20.99 4.07 % $ 3.45 B usaUSA
Keros Therapeutics Keros Therapeutics
KROS
4.72 $ 11.16 1.82 % $ 415 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.35 2.48 % $ 722 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
81.5 K - -5.98 % $ 34.1 M usaUSA